131 related articles for article (PubMed ID: 36628021)
1. Comparison of Clinical Presentation and Vaccine Effectiveness Among Omicron and Non-omicron SARS Coronavirus-2 Patients.
Mohanty M; Mishra B; Singh AK; Mohapatra PR; Gupta K; Patro BK; Sahu DP; Kar P; Purushotham P; Saha S; Das S; Mamidi P; Panda S; Mandal MC; Bhuniya S
Cureus; 2022 Dec; 14(12):e32354. PubMed ID: 36628021
[TBL] [Abstract][Full Text] [Related]
2. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study.
Wang J; Dong H; Zhao J; Li T; Wang M; Zhou C; Mu H
Front Microbiol; 2023; 14():1096022. PubMed ID: 37065120
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022.
Raju MK; Vivian Thangaraj JW; Selvavinayagam TS; Somasundaram A; Parthipan K; Sivadoss R; Sabarinathan R; Subramaniam S; A Rozario AG; Rani SD; Suganya E; Murhekar MV
Indian J Med Res; 2022 Jan; 155(1):165-170. PubMed ID: 35417991
[TBL] [Abstract][Full Text] [Related]
4. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
5. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
[TBL] [Abstract][Full Text] [Related]
6. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
7. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
Papagoras C; Zioga N; Papadopoulos V; Gerolymatou N; Kalavri E; Bounos C; Simopoulou T; Fragoulis GE; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Kravvariti E; Deftereou K; Kougkas N; Zampeli E; Kataxaki E; Melissaropoulos K; Barouta G; Panagiotopoulos A; Koutsianas C; Liossis SN; Georgiou P; Dimitroulas T; Tektonidou MG; Bogdanos DP; Elezoglou A; Voulgari PV; Sfikakis PP; Vassilopoulos D
Clin Rheumatol; 2023 Dec; 42(12):3375-3385. PubMed ID: 37731083
[TBL] [Abstract][Full Text] [Related]
8. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
10. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China.
Yang W; Yang S; Wang L; Zhou Y; Xin Y; Li H; Mu W; Wu Q; Xu L; Zhao M; Wang C; Yu K
Virol Sin; 2022 Oct; 37(5):704-715. PubMed ID: 35948265
[TBL] [Abstract][Full Text] [Related]
12. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
Zeng QL; Lv YJ; Liu XJ; Jiang ZY; Huang S; Li WZ; Yu ZJ
Front Microbiol; 2022; 13():901826. PubMed ID: 35847120
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants associated with temporal succession of SARS-CoV-2 variants in Uttar Pradesh, India.
Pal S; Mehta P; Pandey A; Ara A; Ghoshal U; Ghoshal UC; Pandey R; Tripathi RK; Yadav PN; Ravishankar R; Kundu TK; Rajender S
Front Microbiol; 2023; 14():986729. PubMed ID: 36819024
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of omicron variant in Kangra District of Himachal Pradesh, India during the 3rd disease wave of COVID-19.
Kumar S; Choudhary S; Thakur S; Kumar A; Kumar S
J Infect Dev Ctries; 2023 Apr; 17(4):448-453. PubMed ID: 37159890
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods.
Stupica D; Collinet-Adler S; Kejžar N; Poljak M; Štamol T
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769609
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
Castelli JM; Rearte A; Olszevicki S; Voto C; Del Valle Juarez M; Pesce M; Iovane AN; Paz M; Chaparro ME; Buyayisqui MP; Markiewicz MB; Landoni M; Giovacchini CM; Vizzotti C
BMJ; 2022 Nov; 379():e073070. PubMed ID: 36450402
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2.
Zhang J; Chen N; Zhao D; Zhang J; Hu Z; Tao Z
Front Med (Lausanne); 2022; 9():912367. PubMed ID: 35615088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
